Therapeutic target identification and corresponding drug development is a demanding task for the treatment of lung adenocarcinoma, especially the most malignant proximal-proliferative subtype without ...

1 Department of internal medicine, William Beaumont Hospital, Royal Oak, Michigan, USA 2 Department of internal medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

We all have an appendix. Getting it removed in an emergency in America or Britain can involve a whole different set of ...